Cargando…

Unresectable Recurrent Multiple Meningioma: A Case Report with Radiological Response to Somatostatin Analogues

Medical treatment of meningiomas is reserved for cases in which surgery and radiotherapy have failed. Given that a high percentage of meningiomas express somatostatin receptors, treatment with somatostatin analogues has been proposed. In addition, these medications have been shown to have an antipro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortolá Buigues, Ana, Crespo Hernández, Irene, Jorquera Moya, Manuela, Díaz Pérez, Jose Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043192/ https://www.ncbi.nlm.nih.gov/pubmed/27721778 http://dx.doi.org/10.1159/000448212

Ejemplares similares

Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors
por: Sebastian-Valles, Fernando, et al.
Publicado: (2023)

Somatostatin Receptor Theranostics for Refractory Meningiomas
por: Salgues, Betty, et al.
Publicado: (2022)

Somatostatin Receptors in Human Meningiomas—Clinicopathological Aspects
por: Tollefsen, Sofie Eline, et al.
Publicado: (2021)

Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia
por: Haris, Basma, et al.
Publicado: (2020)

Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
por: Wu, Wei, et al.
Publicado: (2020)

Plurihormonal Pit-1 lineage adenoma presenting as meningitis with recurrence after somatostatin analogue
por: Olmedilla, Yoko, et al.
Publicado: (2019)

Somatostatin Analogues for Receptor Targeted Photodynamic Therapy
por: Kaščáková, Slávka, et al.
Publicado: (2014)

Combined treatment of somatostatin analogues with pegvisomant in acromegaly
por: Franck, S. E., et al.
Publicado: (2015)

Prescription patterns of long-acting somatostatin analogues
por: Machado-Alba, Jorge Enrique, et al.
Publicado: (2017)

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
por: Venegas‐Moreno, Eva, et al.
Publicado: (2017)

Expression of Somatostatin Receptor 2 in Somatotropinoma Correlated with the Short-Term Efficacy of Somatostatin Analogues
por: Liu, Wenjuan, et al.
Publicado: (2017)

Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma
por: Sanjuan-Sanjuan, Alba, et al.
Publicado: (2021)

Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors
por: Watanabe, Hirofumi, et al.
Publicado: (2022)

The potential role of somatostatin analogues in breast cancer treatment.
por: Pollak, M.
Publicado: (1997)

Feasibility of Imaging Esophageal Cancer with Labeled Somatostatin Analogue
por: Herlin, Gunnar, et al.
Publicado: (2011)

Glycemic profile in patients with acromegaly treated with somatostatin analogue
por: Valea, A, et al.
Publicado: (2015)

Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy
por: Collins, Michael, et al.
Publicado: (2018)

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
por: Chin, Sang Ouk, et al.
Publicado: (2019)

Somatostatin analogues labeled with copper radioisotopes: current status
por: Marciniak, Aleksandra, et al.
Publicado: (2017)

Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
por: Ambrosini, Valentina, et al.
Publicado: (2022)

Association of Pathology Markers with Somatostatin Analogue Responsiveness in Acromegaly
por: Kontogeorgos, George, et al.
Publicado: (2022)

Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice
por: Kiesewetter, B., et al.
Publicado: (2022)

The role of somatostatin analogues in treatment of TSH secreting pituitary adenomas
por: Zgliczyński, Wojciech, et al.
Publicado: (2013)

Glucagonoma-associated dilated cardiomyopathy refractory to somatostatin analogue therapy
por: Barabas, Michal, et al.
Publicado: (2019)

Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKD
por: Messchendorp, A. Lianne, et al.
Publicado: (2019)

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
por: Stueven, Anna Kathrin, et al.
Publicado: (2019)

E‐cadherin expression is associated with somatostatin analogue response in acromegaly
por: Venegas‐Moreno, Eva, et al.
Publicado: (2019)

SUN-323 Somatostatin Analogue: An Effective Treatment for Pseudoglucagonoma Syndrome
por: Vallejo Garcia, Franco, et al.
Publicado: (2019)

A Case of Recurrent Anaplastic Meningioma of the Skull Base with Radiologic Response to Hydroxyurea
por: Gurberg, Joshua, et al.
Publicado: (2014)

Case Report: Recurrent meningioma with multiple metastases
por: Zhou, Juyue, et al.
Publicado: (2023)

The efficacy of somatostatin analogues in the treatment of diabetic retinopathy and thyroid eye disease
por: Krassas, Gerasimos E, et al.
Publicado: (2007)

The Effect of Long Acting Somatostatin Analogue SMS 201-995 in Acromegaly
por: Choi, Chul Joon, et al.
Publicado: (1987)

Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement
por: Peverelli, Erika, et al.
Publicado: (2015)

The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
por: Colao, Annamaria, et al.
Publicado: (2015)

Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
por: Alvarez-Escola, Cristina, et al.
Publicado: (2016)

Bilateral Choroidal Metastases from Endobronchial Carcinoid Treated with Somatostatin Analogues
por: De Bruyn, Deborah, et al.
Publicado: (2016)

SPECT/CT with radiolabeled somatostatin analogues in the evaluation of systemic granulomatous infections
por: Monteiro, Paulo Henrique Silva, et al.
Publicado: (2017)

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues
por: van Aerts, René M. M., et al.
Publicado: (2018)

Efficacy and Safety of Everolimus plus Somatostatin Analogues in Patients with Neuroendocrine Tumors
por: Ge, Wenhao, et al.
Publicado: (2018)

Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients
por: Cappellani, Daniele, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_936s6bkfnvsfeia7lick7n2rcm